MiR-638 suppresses the progression of oral squamous cell carcinoma through wnt/β-catenin pathway by targeting phospholipase D1
Source abstract
Abstract
Objective: The current study aimed to explore the function of miR-638 on the progression of oral squamous cell carcinoma (OSCC) and relevant molecular mechanisms.Methods: Expression profile of miR-638 in OSCC tissues and cells was detected using quantitative real-time polymerase chain reaction (qRT-PCR) method. Chi-square test was performed to estimate the relationship between miR-638 and clinical parameters of OSCC cases. Cell viability and motility abilities were estimated using MTT and transwell assays, respectively. Potential targets of miR-638 in OSCC were identified through bioinformatics analysis and luciferase reporter assay.Results: MiR-638 exhibited decreased expression in OSCC tissues and cells, compared to non-cancerous controls (P < .05 for both). Moreover, its down-regulation was closely correlated with lymph node metastasis (P = .044) and TNM stages (P = .001). Enforced miR-638 expression reduced cell proliferation, migration and invasion, while its knockdown exhibited opposite effects. Phospholipase D1 (PLD1) was confirmed as a target of miR-638 in OSCC. MiR-638 could inhibit wnt/β-catenin pathway through targeting PLD1, thus realizing its anti-tumour action in OSCC.Conclusion: MiR-638 may be a tumour suppressor in OSCC by targeting PLD1/Wnt/β-catenin pathway.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: MicroRNA in disease regulation · Cancer-related molecular mechanisms research · Circular RNAs in diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of VIP Center and Shandong Provincial Key Laboratory of Oral Biomedicine, School and Hospital of Stomatology, Shandong University
Department of Endodontics, Jinan Stomatological Hospital
Department of Oral prosthology, Jinan Stomatological Hospital
Department of Stomatology, Affiliated Hospital of Binzhou Medical College
References (32)
Show source-provided references
1. 10.3322/caac.2138710.3322/caac.21387 ↗
2. Rivera C. Essentials of oral cancer. Int J Clin Exp Pathol. 2015;8:11884–11894.
3. 10.4103/0973-1482.18669610.4103/0973-1482.186696 ↗
4. 10.1016/j.coms.2018.08.00210.1016/j.coms.2018.08.002 ↗
5. 10.4317/medoral.1877210.4317/medoral.18772 ↗
6. 10.1038/sj.bdj.2018.92610.1038/sj.bdj.2018.926 ↗
7. 10.1016/j.mcna.2014.08.00510.1016/j.mcna.2014.08.005 ↗
8. 10.3390/ijms1903067010.3390/ijms19030670 ↗
9. 10.1186/s12986-018-0305-810.1186/s12986-018-0305-8 ↗
10. 10.1016/j.addr.2015.05.00110.1016/j.addr.2015.05.001 ↗
11. 10.1093/infdis/jiv19710.1093/infdis/jiv197 ↗
12. 10.18632/oncotarget.1835010.18632/oncotarget.18350 ↗
13. 10.1124/jpet.117.24263610.1124/jpet.117.242636 ↗
14. 10.3892/ol.2017.588210.3892/ol.2017.5882 ↗
15. 10.1007/s13277-016-5379-110.1007/s13277-016-5379-1 ↗
16. 10.1007/s13238-015-0187-810.1007/s13238-015-0187-8 ↗
17. 10.2147/OTT.S18203410.2147/OTT.S182034 ↗
18. Wei H, Zhang JJ, Tang QL. MiR-638 inhibits cervical cancer metastasis through Wnt/beta-catenin signalling pathway and correlates with prognosis of cervical cancer patients. Euro Rev Med Pharmacol Sci. 2017;21:5587–5593.
19. Sciubba JJ, Larian B. Oral squamous cell carcinoma: early detection and improved 5-year survival in 102 patients. General Dentistry 2018;66:e11–e16.
20. Prasad G, Seers C, Reynolds E, et al. A panel of microRNAs can be used to determine oral squamous cell carcinoma. J Oral Pathol Med: Off Public Int Assoc Oral Pathol Am Acad Oral Pathol. 2017;46:940–948.10.1111/jop.12592 ↗
21. 10.18632/oncotarget.2256710.18632/oncotarget.22567 ↗
22. 10.1002/jcb.2665010.1002/jcb.26650 ↗
23. 10.1007/978-1-4939-6524-3_110.1007/978-1-4939-6524-3_1 ↗
24. 10.1038/nrd.2016.25210.1038/nrd.2016.252 ↗
25. 10.1074/jbc.R114.57687610.1074/jbc.R114.576876 ↗
26. 10.18632/oncotarget.1896110.18632/oncotarget.18961 ↗
27. 10.1042/CS2016008710.1042/CS20160087 ↗
28. 10.4161/cbt.2816510.4161/cbt.28165 ↗
29. 10.1158/0008-5472.CAN-09-347010.1158/0008-5472.CAN-09-3470 ↗
30. 10.1158/1078-0432.CCR-17-074910.1158/1078-0432.CCR-17-0749 ↗
31. 10.1371/journal.pone.001210910.1371/journal.pone.0012109 ↗
32. Rheinwald JG, Beckett MA. Tumourigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Cancer Res. 1981;41:1657–1663.